Iker Arabaolaza-Rodriguez
Bristol, ENG BS28HW, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Targeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new anti-cancer strategy.
Journal: Journal of experimental & clinical cancer research : CR
Published: October 15, 2023
CD69 expression on regulatory T cells protects from immune damage after myocardial infarction.
Journal: The Journal of clinical investigation
Published: June 16, 2021
Umbilical Cord Pericytes Provide a Viable Alternative to Mesenchymal Stem Cells for Neonatal Vascular Engineering.
Journal: Frontiers in cardiovascular medicine
Published: September 24, 2020
Role of TPBG (Trophoblast Glycoprotein) Antigen in Human Pericyte Migratory and Angiogenic Activity.
Role of TPBG (Trophoblast Glycoprotein) Antigen in Human Pericyte Migratory and Angiogenic Activity.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: April 26, 2019
MicroRNA-532-5p Regulates Pericyte Function by Targeting the Transcription Regulator BACH1 and Angiopoietin-1.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: March 12, 2018
Transplantation of Allogeneic Pericytes Improves Myocardial Vascularization and Reduces Interstitial Fibrosis in a Swine Model of Reperfused Acute Myocardial Infarction.
Journal: Journal of the American Heart Association
Published: January 24, 2018
The adipokine leptin modulates adventitial pericyte functions by autocrine and paracrine signalling.
The adipokine leptin modulates adventitial pericyte functions by autocrine and paracrine signalling.
Journal: Scientific reports
Published: August 30, 2016
Design, fabrication and perivascular implantation of bioactive scaffolds engineered with human adventitial progenitor cells for stimulation of arteriogenesis in peripheral ischemia.
Journal: Biofabrication
Published: March 25, 2016
Expansion and characterization of neonatal cardiac pericytes provides a novel cellular option for tissue engineering in congenital heart disease.
Journal: Journal of the American Heart Association
Published: June 18, 2015
Last Updated: 09/26/2026